Monday, July 19, 2021

Mesoblast reports 90-day enhanced survival outcomes for remestemcel-L w/ Covid/ARDS

... Society for Cell & Gene Therapy (ISCT) Scientific Signatures Series on Cell and Gene Therapies in Lung Diseases and Critical Illnesses.
https://www.google.com/url?rct=j&sa=t&url=https://www.thepharmaletter.com/article/mesoblast-reports-90-day-enhanced-survival-outcomes-for-remestemcel-l-w-covid-ards&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNG2EQgio85LGac04jlWM0-RISdsLw

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...